European Patent Office Revokes Myriad Genetics BRCA1 Patent

May 19, 2004

NEW YORK, May 19 (GenomeWeb News) - The European Patent Office yesterday revoked a patent linked to Myriad Genetic's pioneering BRCA1 molecular diagnostic.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Pressure BioSciences Q2 Revenues Up 6 Percent
Sequencing of Circulating Tumor DNA Detects Early Cancers
LabCorp Prices $1.2B Senior Notes Offering
Monsanto Licenses ToolGen CRISPR Technology
Curetis Posts 9 Percent Drop in H1 Revenues
PerkinElmer Inks $200M Loan Agreement

The Scan

Prize for Five

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Sure, Blame the Test

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

This Week in Genome Research

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Low Down Syndrome Rates in Iceland

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.

Main menu